Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-150916

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John McGrath
Officer — Chief Financial Officer
Period of report
Nov 15, 2016
Accepted (ET)
Nov 17, 2016 · 4:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 15, 2016M2,805$0.00A92,128D
Common StockF1Nov 15, 2016M7,698$0.00A99,826D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F2,F3,F4—Nov 15, 2016M2,805D——Common Stock2,8053,739I
Restricted Stock UnitsF5,F2,F6,F7—Nov 15, 2016M7,698D——Common Stock7,69835,921I

Explanation of responses